| Name | Ligelizumab |
|---|
| Description | Ligelizumab (QGE 031) is a humanized high-affinity monoclonal anti-IgE antibody. Ligelizumab can be used for the research of chronic spontaneous urticarial[1]. |
|---|---|
| Related Catalog | |
| Target |
IgE[1] |
| References |
| No Any Chemical & Physical Properties |